2 completed, 2 recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 2 |
| Phase 2 | 2 | Recruiting 2 |
Follow Letrozole tablets: new trials by email Literature Review of Letrozole tablets trials Research Report on Letrozole tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer HRS-6208 Capsule, HRS-6209 Capsule, HRS-8080 Tablet - Advanced Unresectable or Metastatic Breast Cancer of Adults | Phase 1 / Phase 2 | Recruiting | Shandong Suncadia Medicine Co., Ltd. | 180 | 2026-03-27 | 2026-04-03 |
| A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer HRS-6209 Capsules, Letrozole Tablets, HRS-2189 Tablets - Breast Cancer | Phase 1 / Phase 2 | Recruiting | Jiangsu HengRui Medicine Co., Ltd. | 80 | 2025-05-22 | 2026-06-12 |
| Letrozole Alone Protocol Versus Using Letrozole and HCG Protocol Letrozole tablets - PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Phase 1 | Completed | Egymedicalpedia | 132 | 2022-11-10 | 2024-04-16 |
| Phase I Study of BEBT-209 in Women With Advanced Breast Cancer BEBT-209 capsules, Letrozole tablets, Fulvestrant - Advanced Breast Cancer | Phase 1 | Completed | BeBetter Med Inc | 100 | 2019-07-15 | 2026-08-18 |
Breast Neoplasms (1) · Polycystic Ovary Syndrome (1)
BeBetter Med Inc (1) · Egymedicalpedia (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Shandong Suncadia Medicine Co., Ltd. (1)
China (3) · Egypt (1)
Quchang Ouyang, Phd (1) · Shouman Wang, Phd (1)